NEWS on cardiovascular, respiratory system implants
Inferior Vena Cava Filter Use / Mortality Rates in Older Adults With Acute Pulmonary Embolism
(more…)
Risk of Death Following Application of Paclitaxel‐Coated Balloons and Stents in the Femoropopliteal Artery
(more…)
Risk of Death Following Application of Paclitaxel‐Coated Balloons and Stents in the Femoropopliteal Artery of the Leg (Systematic Review/Meta‐Analysis)
(more…)
Drug-coated balloons for small coronary artery disease
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial Jeger RV, et al. In small native coronary artery disease, DCB was non-inferior to DES regarding MACE up to 12 months, with similar event rates for both treatment groups. The Lancet, Articles| Volume 392, ISSUE 10150,...
Drug-eluting stents (DES) superior versus bare-metal stents
In the ISAR-CABG (Is Drug-Eluting-Stenting Associated with Improved Results in Coronary Artery Bypass Grafts?) trial, clinical outcomes at 1 year in patients undergoing treatment of saphenous vein graft lesions were superior with drug-eluting stents (DES) versus bare-metal stents. R Colleran et al. Patients were randomized (1:1:1:3) to receive DES (either...
Transcatheter Mitral Valve Technologies
Transcatheter Mitral Valve Technologies: The Heart of Cardiovascular Device Innovation Bawa TS, Hoffmann M, Thompson S, Kwei S The current atmosphere in medical device investment is one of caution: Over the last five years, about two-thirds of high-impact medical device M&A deals have occurred following U.S. commercialization1, that is, after...
Find NEWS and PUBLICATIONS here according to your interests or use the search box.
